These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3870249)

  • 61. Effect of uninephrectomy on urinary prostaglandin E2, F2 alpha, and 6-ketoprostaglandin F1 alpha excretion in rats.
    Baer PG; Nasjletti A
    Clin Sci (Lond); 1984 Apr; 66(4):407-13. PubMed ID: 6583033
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
    Schwarz HA; Weidmann P; Messerli FH; Zia PK; Flammer J; Reubi RC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1870-2. PubMed ID: 929154
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Bartter's or pseudo-Bartter's syndrome?].
    Knotková V; Benes R; Stejskalová A; Jindra A; Kucerová V
    Cas Lek Cesk; 1985 Feb; 124(7):213-7. PubMed ID: 3971411
    [No Abstract]   [Full Text] [Related]  

  • 64. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
    Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F
    J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical analysis of drug-induced Pseudo-Bartter's syndrome: a report of five cases].
    Li FA; Wei HY; Lin S; Han HL; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(18):1278-80. PubMed ID: 22883069
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Factitious Bartter's syndrome.
    Rosenblum M; Simpson DP; Evenson M
    Arch Intern Med; 1977 Sep; 137(9):1244-5. PubMed ID: 901095
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Urinary chloride excretion in suspected Bartter's syndrome.
    Chan MK; Varghese Z; Moorhead JF
    N Engl J Med; 1979 Dec; 301(26):1450. PubMed ID: 514332
    [No Abstract]   [Full Text] [Related]  

  • 69. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional interpretation of the kidney juxtaglomerular apparatus using renin immunohistochemistry in Bartter's, pseudo-Bartter's and Conn's syndromes.
    Lertprasertsuke N; Kakudo K; Osamura Y; Nomoto Y; Sakai H; Watanabe K
    Tokai J Exp Clin Med; 1990 Jul; 15(4):317-26. PubMed ID: 2130539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lack of evidence for a role for prostaglandins in the mediation of impaired urinary concentrating ability in Bartter's syndrome.
    Chan JC; Gill JR; Bartter FC
    Nephron; 1983; 35(2):116-9. PubMed ID: 6621756
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glomerular hyperfiltration and urinary prostaglandins in type 1 diabetes mellitus.
    Viberti GC; Benigni A; Bognetti E; Remuzzi G; Wiseman MJ
    Diabet Med; 1989 Apr; 6(3):219-23. PubMed ID: 2523782
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A familial disorder with hypokalemic alkalosis, hyperreninemia, aldosteronism, high urinary prostaglandins and normal blood pressure that is not "Bartter's syndrome".
    Güllner HG; Gill JR; Bartter FC; Chan JC; Dickman PS
    Trans Assoc Am Physicians; 1979; 92():175-88. PubMed ID: 398615
    [No Abstract]   [Full Text] [Related]  

  • 75. Relationship of renal prostaglandins to distal transport of sodium chloride in normokalemic and hypokalemic man.
    Favre L; Williams G; Favre H; Paunier L; Vallotton MB
    Miner Electrolyte Metab; 1985; 11(3):186-91. PubMed ID: 4010649
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studies on the pathogenesis of Bartter's syndrome.
    Baehler RW; Work J; Kotchen TA; McMorrow G; Guthrie G
    Am J Med; 1980 Dec; 69(6):933-8. PubMed ID: 7446558
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Renal function and urinary prostaglandins in rats given an adenine diet.
    Yokozawa T; Chung HY; Lee TW; Oura H
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):671-5. PubMed ID: 2795996
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A defect in platelet aggregation in Bartter's syndrome.
    Stoff JS; Stemerman M; Steer M; Salzman E; Brown RS
    Am J Med; 1980 Feb; 68(2):171-80. PubMed ID: 6243857
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy.
    Jouve R; Rolland PH; Delboy C; Mercier C
    Am Heart J; 1984 Jan; 107(1):45-52. PubMed ID: 6581715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.